Our Portfolio:

BaroSense, Inc., Redwood City, CA
barosense.com

BaroSense is focused on a minimally invasive device-based treatment for obesity. Obesity is considered the second leading cause of unnecessary death in the U.S. BaroSense has assembled thought leaders from gastroenterology, bariatric surgery, endocrinology, and interventional cardiology to tackle the growing epidemic of obesity.


InnerPulse, Inc., Research Triangle Park, NC
inner-pulse.com

InnerPulse (formerly IRM) has developed the world's first fully intravascular, non-surgically implanted cardiac defibrillator (ICD) for the prevention of sudden cardiac death. These features enable much easier and faster implantation as well as a shift in the customer / operator to the huge Interventional Cardiology market. The product has the potential to create enormous customer preference.


iRhythm Technologies, Inc., San Francisco, CA
irhythmtech.com

iRhythm Technologies, Inc. is an early-stage development venture pursuing novel approaches in cardiology.


Oraya Therapeutics, Inc., Newark, CA
orayainc.com

Oraya Therapeutics, Inc. is an early-stage development venture pursuing novel approaches in ophthalmology.


Synecor, LLC, Research Triangle Park, NC
synecor.com

Synecor, LLC is a medical device incubator focused on a variety of therapeutic areas including: cardiology, obesity, spine therapeutics and more.


TransEnterix, Inc., Research Triangle Park, NC

TransEnterix, Inc. is an early-stage development venture focused on minimally invasive surgical tools.